Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease

British Journal of Nutrition

Volumn 112, Issue 1, 2014, Pages 30-40

  Olivares, Marta ^a   Castillejo, Gemma ^b   Varea, Vicente ^c   Sanz, Yolanda ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

^b HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Bifidobacterium longum CECT 7347; Coeliac disease; Gluten free diet; Probiotics

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 13; PLACEBO; PROBIOTIC AGENT; SECRETORY IMMUNOGLOBULIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; CD45 ANTIGEN; IMMUNOGLOBULIN A;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; BACTERIAL COUNT; BACTEROIDES FRAGILIS; BIFIDOBACTERIUM; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM CECT 7347; BLOOD EXAMINATION; BODY HEIGHT; BODY WEIGHT; CD3+ T LYMPHOCYTE; CELIAC DISEASE; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CLOSTRIDIUM; CLOSTRIDIUM COCCOIDES; CLOSTRIDIUM LEPTUM; CONSTIPATION; CONTROLLED STUDY; CYTOKINE RELEASE; DIARRHEA; DIETARY COMPLIANCE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENTEROBACTERIACEAE; FECES LEVEL; FEMALE; GLUTEN FREE DIET; HEALTH STATUS; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPHENOTYPING; INTERVENTION STUDY; INTESTINE FLORA; LACTOBACILLUS; LYMPHOCYTE COUNT; MALE; MULTICENTER STUDY; NONHUMAN; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SPECIES COMPOSITION; VOMITING; BACTERIUM EXAMINATION; DECREASED APPETITE; DRUG DETERMINATION; DRUG MECHANISM; DRUG SCREENING; DRUG WITHDRAWAL; FECES ANALYSIS; GENE DOSAGE; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; WEIGHT GAIN;

BACTEROIDES FRAGILIS; BIFIDOBACTERIUM LONGUM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BACTEROIDES FRAGILIS; BIFIDOBACTERIUM; CELIAC DISEASE; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYTOKINES; DIET, GLUTEN-FREE; DOUBLE-BLIND METHOD; FECES; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; INTESTINAL MUCOSA; MALE; MICROBIAL VIABILITY; PROBIOTICS;

EID: 84902547544     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114514000609     Document Type: Article

References (44)

1. Di Sabatino A & Corazza GR (2009) Coeliac disease. Lancet 373, 1480-1493.
2. Pozo-Rubio T, Olivares M, Nova E, et al. (2012) Immune development and intestinal microbiota in celiac disease. Clin Dev Immunol 2012, 654143.
3. Laparra M, Olivares M & Sanz Y (2013) Role of gut microbes in celiac disease risk and pathogenesis. In Celiac Disease. Chapter 7 [S Devi Rampertab and E Gerand, editors]. Dordrecht: Springer.
4. Kalliomäki M, Satokari R, Lähteenoja H, et al. (2012) Expression of microbiota, Toll-like receptors, and their regulators in the small intestinal mucosa in celiac disease. J Pediatr Gastroenterol Nutr 54, 727-732.
5. de Meij TG, Budding AE, Grasman ME, et al. (2013) Composition and diversity of the duodenal mucosa-associated microbiome in children with untreated coeliac disease. Scand J Gastroenterol 48, 530-536.
6. Nadal I, Donat E, Ribes-Koninckx C, et al. (2007) Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol 56, 1669-1674.
7. Collado MC, Donat E, Ribes-Koninckx C, et al. (2008) Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease. BMC Microbiol 8, 232.
8. Sanz Y, De Palma G & Laparra M (2011) Unraveling the ties between celiac disease and intestinal microbiota. Int Rev Immunol 30, 207-218.
9. Wacklin P, Kaukinen K, Tuovinen E, et al. (2013) The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease. Inflamm Bowel Dis 19, 934-941.
10. Medina M, De Palma G, Ribes-Koninckx C, et al. (2008) Bifidobacterium straits suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients. J Inflamm (London) 5, 19.
11. De Palma G, Nadal I, Medina M, et al. (2010) Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol 10, 63.
12. Cinova J, De Palma G, Stepankova R, et al. (2011) Role of intestinal bacteria in gliadin-induced changes in intestinal mucosa: study in germ-free rats. PLoS One 6, e16169.
13. Sánchez E, Laparra JM & Sanz Y (2012) Discerning the role of Bacteroides fragilis in celiac disease pathogenesis. Appl Environ Microbiol 78, 6507-6515.
14. De Palma G, Kamanova J, Cinova J, et al. (2012) Modulation of phenotypic and functional maturation of dendritic cells by intestinal bacteria and gliadin: relevance for celiac disease. J Leukocyte Biol 92, 1043-1054.
15. Laparra JM & Sanz Y (2010) Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion. J Cell Biochem 109, 801-807.
16. Olivares M, Laparra M & Sanz Y (2011) Influence of Bifidobacterium longum CECT 7347 and gliadin peptides on intestinal epithelial cell proteome. J Agric Food Chem 59, 7666-7671.
17. Laparra JM, Olivares M, Gallina O, et al. (2012) Bifidobacterium longum CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal model. PLoS One 7, e30744.
18. Agardh D, Lynch K, Brundin C, et al. (2006) Reduction of tissue transglutaminase autoantibody levels by glutenfree diet is associated with changes in subsets of peripheral blood lymphocytes in children with newly diagnosed coeliac disease. Clin Exp Immunol 144, 67-75.
19. Cseh Á, Vásárhelyi B, Szalay B, et al. (2011) Immune phenotype of children with newly diagnosed and gluten-free diettreated celiac disease. Dig Dis Sci 56, 792-798.
20. Cosnes J, Cellier C, Viola S, et al. (2008) Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol 6, 753-758.
21. Malandrino N, Capristo E, Farnetti S, et al. (2008) Metabolic and nutritional features in adult celiac patients. Dig Dis 26, 128-133.
22. Roos S, Wilhelmsson S & Hallert C (2011) Swedish women with coeliac disease in remission use more health care services than other women: a controlled study. Scand J Gastroenterol 46, 13-19.
23. Turco R, Boccia G, Miele E, et al. (2011) The association of coeliac disease in childhood with functional gastrointestinal disorders: a prospective study in patients fulfilling Rome III criteria. Aliment Pharmacol Ther 7, 783-789.
24. Paavola A, Kurppa K, Ukkola A, et al. (2012) Gastrointestinal symptoms and quality of life in screen-detected celiac disease. Dig Liver Dis 10, 814-818.
25. Di Sabatino A, Bertrandi E, Casadei Maldini M, et al. (1998) Phenotyping of peripheral blood lymphocytes in adult celiac disease. Immunology 95, 572-576.
26. Rubio-Tapia A, Barton SH, Rosenblatt JE, et al. (2009) Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol 43, 157-161.
27. Sanz Y (2009) Novel perspectives in celiac disease therapy. Mini-Rev Med Chem 9, 359-367.
28. Farran A, Zamora R & Cervera P (2004) Tablas de composicio ́n de alimentos CESNID (CESNID Food Composition Tables), 2nd ed. Barcelona: McGraw-Hill/Interamericana.
29. Yu Y, Lee C, Kim J, et al. (2005) Group-specific primer and probe sets to detect methanogenic communities using quantitative real-time polymerase chain reaction. Biotechnol Bioeng 89, 670-679.
30. Birnboim HC & Doly J (1979) A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res 7, 1513-1523.
31. Radlović N, Mladenović M, Leković Z, et al. (2009) Effect of gluten-free diet on the growth and nutritional status of children with coeliac disease. Srp Arh Celok Lek 137, 632-637.
32. Damen GM, Boersma B, Wit JM, et al. (1994) Catch-up growth in 60 children with celiac disease. J Pediatr Gastroenterol Nutr 19, 394-400.
33. Taavela J, Kurppa K, Collin P, et al. (2013) Degree of damage to the small bowel and serum antibody titers correlate with clinical presentation of patients with celiac disease. Clin Gastroenterol Hepatol 11, 166-171.
34. Myśliwiec M, Balcerska A, Zorena K, et al. (2008) Immunologic and biochemical factors of coincident celiac disease and type 1 diabetes mellitus in children. Pediatr Res 64, 677-681.
35. Street ME, Volta C, Ziveri MA, et al. (2008) Changes and relationships of IGFS and IGFBPS and cytokines in coeliac disease at diagnosis and on gluten-free diet. Clin Endocrinol (Oxf) 68, 22-28.
36. Fasano A & Shea-Donohue T (2005) Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol 2, 416-422.
37. Bayardo M, Punzi F, Bondar C, et al. (2012) Transglutaminase 2 expression is enhanced synergistically by interferon-g and tumour necrosis factor-a in human small intestine. Clin Exp Immunol 168, 95-104.
38. Rabizadeh S, Rhee KJ, Wu S, et al. (2007) Enterotoxigenic Bacteroides fragilis: a potential instigator of colitis. Inflamm Bowel Dis 13, 1475-1483.
39. De Palma G, Nadal I, Collado MC, et al. (2009) Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects. Br J Nutr 102, 1154-1160.
40. Scott KP, Martin JC, Duncan SH, et al. (2013) Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. FEMS Microbiol Ecol 87, 30-40.
41. Peterson DA, McNulty NP, Guruge JL, et al. (2007) IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2, 328-339.
42. Kawamoto S, Tran TH, Maruya M, et al. (2012) The inhibitory receptor PD-1 regulates IgA selection and bacterial composition in the gut. Science 336, 485-489.
43. Delcenserie V, Martel D, Lamoureux M, et al. (2008) Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol Biol 10, 37-54.
44. Smecuol E, Hwang HJ, Sugai E, et al. (2013) Exploratory, randomized, double-blind, placebo-controlled study on the effects of Bifidobacterium infantis natren life start strain super strain in active celiac disease. J Clin Gastrooenterol 47, 139-147.